 In this study, the efficacy of the cannabis treatment on pain and related quality of life QoL outcomes will be assessed by administering the S-TOPS questionnaire Haroutiunian, Pain 2012, and the Brief Pain Inventory BPI before the treatment baseline, and on expected follow-up visits at approximately 6 and 12 months. 